Rachel Haring - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Rachel Haring

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Current Opinion in Drug Discovery & Development|March 13, 2003

Bioactive lipids and their receptorsItzchak Angel, Adina Bar, Rachel Haring

Journal of Molecular Neuroscience : MN|September 6, 2002

AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's diseaseAbraham Fisher, Rachel Brandeis, Rachel Haring Nira Bar-Ner, et al.

Journal of Molecular Neuroscience : MN|September 23, 2003

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapyAbraham Fisher, Zipora Pittel, Rachel Haring, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Current Opinion in Drug Discovery & Development|March 13, 2003

Bioactive lipids and their receptorsItzchak Angel, Adina Bar, Rachel Haring

Journal of Molecular Neuroscience : MN|September 6, 2002

AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's diseaseAbraham Fisher, Rachel Brandeis, Rachel Haring Nira Bar-Ner, et al.

Journal of Molecular Neuroscience : MN|September 23, 2003

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapyAbraham Fisher, Zipora Pittel, Rachel Haring, et al.

Pageof 1